Log In
BCIQ
Print this Print this
 

NNI-362

  Manage Alerts
Collapse Summary General Information
Company NeuroNascent Inc.
DescriptionPromotes new neuron growth from neuronal progenitor cells
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today